CDMRP: Bone Marrow Failure Research Program Investigator-Initiated Research Award

The BMFRP Investigator-Initiated Research Award is intended to support meritorious research focused on BMF diseases.

Relevant diseases include (but are not limited to): 

• Aplastic Anemia • Diamond-Blackfan Anemia • Dyskeratosis Congenita/Telomere Biology Disorders • Fanconi Anemia • GATA2 Deficiency • Induced BMF: Radiation/Chemical • Myelodysplastic Syndromes • Paroxysmal Nocturnal Hemoglobinuria • Pearson’s Disease • SAMD9/SAMD9L Germline Mutations • Severe Congenital Neutropenia • Shwachman-Diamond Syndrome

Applications must address at least one focus area: 

• Understand the causes and progression of BMF diseases
• Find effective BMF treatments and cures

The FY23 BMFRP Investigator-Initiated Research Award will offer two funding levels with different intent:
Funding Level 1 (FL1): To support studies that further develop ideas, expand upon key discoveries, and have the potential to make significant advances in research, patient care, and/or quality of life.

Funding Level 2 (FL2): To support Investigational New Drug (IND)-enabling efforts.

It is expected that two (2) awards will be granted. 

Funding: Level 1- $675,000 total; Level 2- $850,000 total 
Duration: Level 1- 3 years; Level 2- 2 years 

Research Authority due date: 14.6.23

Pre application (required) due date: 21.6.23

Full proposal due date: 20.9.23